Research risk for persons with psychiatric disorders: A decisional framework to meet the ethical challenge

Psychiatric Services

Volumn 60, Issue 3, 2009, Pages 374-383

  Yanos, Philip T ^a   Stanley, Barbara S ^b   Greene, Carolyn S ^c  

^a JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c Children's Aid Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61749099252     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2009.60.3.374     Document Type: Article

References (55)

1. Research Involving Those Institutionalized as Mentally Infirm. Washington, DC, Department of Health, Education and Welfare, 1978
2. Exhibit A: Research involving persons with psychiatric disorders that may affect decision making capacity, in National Bioethics Advisory Commission 1998-1999 Biennial Report. Washington, DC, National Bioethics Advisory Commission, 1999. Available at www.bioethics.gov
3. Research Involving Individuals With Questionable Capacity to Consent: Points to Consider. Washington, DC, Department of Health and Human Services, Office of Intramural Research, Mar 11, 1999. Available at www.grants.nih.gov/ grants
4. Special classes of subjects, in Institutional Review Board Guidebook. Washington, DC, US Department of Health and Human Services, 2007. Available at www.hhs.gov/ohrp
5. Office for Human Research Protections, Department of Health and Human Services: Request for information and comments on research that involves adult individuals with impaired decision-making capacity. Federal Register 72:50966-50970, 2007
6. American Psychiatric Association's Task Force on Research Ethics: Ethical principles and practices for research involving human participants with mental illness. Psychiatric Services 57:552-557, 2006
7. McWilliams NA, Jones EL, Davies RJ: Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA 290:360-366, 2003
8. Silverman H, Hull SC, Sugarman J: Variability among institutional review boards' decisions within the context of a multicenter trial. Critical Care Medicine 29:235-241, 2001
9. Larson E, Bratts T, Zwanziger J, et al: A survey of IRB process in 68 US hospitals. Journal of Nursing Scholarship 36:260-264, 2004
10. Hirshon JM, Krugman SD, Witting MD, et al: Variability in institutional review board assessment of minimal-risk research. Academic Emergency Medicine 9:1417-1420, 2002
11. Michels R: Are research ethics bad for our mental health? New England Journal of Medicine 340:1427-1430, 1999
12. Boothroyd RA: The impact of research participation on adults with severe mental illness. Mental Health Services Research 2:213-222, 2000
13. Newman E, Kaloupek DG: The risks and benefits of participating in trauma-focused research studies. Journal of Traumatic Stress 17:383-394, 2004
14. Jorm AF, Kelly CM, Morgan AJ: Participant distress in psychiatric research: a systematic review. Psychological Medicine 27:917-926, 2007
15. Roberts LW, Warner TD, Hammond KG, et al: Assessments by patients with schizophrenia and psychiatrists of relative risk of research procedures. Psychiatric Services 57:1629-1635, 2006
16. Roberts LW, Dunn LB, Hammond KG, et al: Do research procedures pose relatively greater risk for healthy persons than for persons with schizophrenia? Schizophrenia Bulletin 32:153-158, 2006
17. Roberts LW, Warner TD, Brody JL, et al: Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions. American Journal of Psychiatry 159:573-584, 2002
18. Stanley B, Stanley M, Lautin A, et al: Preliminary findings on psychiatric patients as research participants: a population at risk? American Journal of Psychiatry 138:669-671, 1981
19. Widom CS, Czaja S: Reactions to research participation in vulnerable subgroups. Accountability in Research 12:115-138, 2005
20. Carpenter WT, Gold JM, Lahti AC, et al: Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry 5:533-538, 2000
21. Palmer BW, Dunn LB, Appelbaum PS, et al: Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, diabetes mellitus. Archives of General Psychiatry 62:726-733, 2005
22. Kovnick JA, Appelbaum PS, Hoge SK, et al: Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatric Services 54:1247-1252, 2003
23. Wirshing DA, Wirshing WC, Marder SR, et al: Informed consent: assessment of comprehension. American Journal of Psychiatry 155:1508-1511, 1998
24. Dunn LB: Capacity to consent to research in schizophrenia: the expanding evidence base. Behavioral Sciences and the Law 24:431-445, 2006
25. Rosenstein DL, Miller FG: Ethical considerations in psychopharmacological research involving decisionally impaired subjects. Psychopharmacology 171:92-97, 2003
26. Levine C, Faden R, Grady C, et al: The limitations of "vulnerability" as a protection for human research participants. American Journal of Bioethics 3:44-49, 2004
27. Vulnerable Populations. Durham, NC, Duke University, Office of Research Support, 2007. Available at www.ors.duke.edu/irb
28. Silvers A: Historical vulnerability and special scrutiny: precautions against discrimination in medical research. American Journal of Bioethics 3:56-57, 2004
29. Rosenfeld B, Turkheimer E, Gardner W: Decision making in a schizophrenic population. Law and Human Behavior 16:651-662, 1992
30. Appelbaum PS, Grisso T, Frank E, et al: Competence of depressed patients for consent to research. American Journal of Psychiatry 156:1380-1384, 1999
31. Stiles PG, Poythress NG, Hall A, et al: Improving understanding of research consent disclosures among persons with mental illness. Psychiatric Services 52:780-785, 2001
32. Cohen BJ, McGarvery EL, Pinkerton RC, et al: Willingness and competence of depressed and schizophrenic inpatients to consent to research. Journal of the American Academy of Psychiatry and the Law 32:134-143, 2004
33. Fisher CB, Pearson JL, Kim S, et al: Ethical issues in including suicidal individuals in clinical research. IRB: Ethics and Human Research 24:9-14, 2002
34. Zimbardo PG, Leippe MR.: The Psychology of Attitude Change and Social Influence. New York, McGraw-Hill, 1991
35. Peternelj-Taylor AC: Conceptualizing nursing research with offenders: another look at vulnerability. International Journal of Law and Psychiatry 28:348-359, 2005
36. Miskimen T, Marin H, Escobar J: Psychopharmacological research ethics: special issues affecting US ethnic minorities. Psychopharmacology 171:98-104, 2003
37. Fisher CB: Ethics in drug abuse and related HIV risk research. Applied Developmental Science 8:91-103, 2004
38. Wendler D, Prasad K: Core safeguards for clinical research with adults who are unable to consent. Annals of Internal Medicine 135:514-523, 2001
39. Submission Guidelines for All New Studies. Kokomo, Indiana University Kokomo, Institutional Review Board for the Protection of Human Subjects. Available at www.iuk.edu/~koirb/submissionguidelines.shtml
40. Boothroyd R, Best K: Emotional reactions to research participation and the relationship to understanding of informed consent disclosure. Social Work Research 27:242-251, 2003
41. Roberts LW, Hammond KG, Hoop J: An inverse relationship between perceived harm and participation willingness in schizophrenia research protocols. American Journal of Psychiatry 163:2002-2004, 2006
42. Jacomb PA, Jorm AF, Rodgers B, et al: Emotional response of participants to a mental health survey. Social Psychiatry and Psychiatric Epidemiology 34:80-84, 1999
43. Recommendations on the Oversight of Research Involving the Protected Classes. Albany, New York State Department of Health, Advisory Work Group on Human Subject Research Involving the Protected Classes, 1998. Available at purl.org/net/nysl/nysdocs/49377072
44. Labott SM, Johnson TP: Psychological and social risks of behavioral research. IRB: Ethics and Human Research 26:11-15, 2004
45. Assessing the Research Risk. St Louis, Washington University, Human Research Protection Office, 2004. Available at https:// hrpo.wustl.edu/HRPO/ resource/doc/DOC000748/minimalriskguideline.rtf
46. The Unethical Use of Human Beings in High Risk Research Experiments. Testimony by Adil E Shamoo before the Subcommittee on Oversight, Committee on Veterans Affairs, US House of Representatives, Apr 1, 1999. Available at www.house.gov/va/hearings/schedule106/apr99/4-21-99J/shamoo.htm
47. Hall LL: NAMI Consumer Views of Research. Arlington, Va, National Alliance on Mental Illness, Jan 2001. Available at www.nami.org
48. Wyatt RJ, Henter ID, Bartko JJ: The long-term effects of placebo in patients with chronic schizophrenia. Biological Psychiatry 46:1092-1105, 1999
49. Jeste DV, Palmer BW, Harris MJ: Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas. Biological Psychiatry 46:1050-1059, 1999
50. Grunebaum MF, Oquendo MA, Burke AK, et al: Clinical impact of a 2-week psychotropic medication washout in unipolar depressed inpatients. Journal of Affective Disorders 75:291-296, 2003
51. Lahti AC, Warfel D, Michaelidis T, et al: Long-term outcome of patients who receive ketamine during research. Biological Psychiatry 49:869-875, 2001
52. Carpenter WT: The schizophrenia ketamine challenge study debate. Biological Psychiatry 46:1081-1091, 1999
53. Koocher GP: Using the CABLES model to assess and minimize risk in research: control group hazards. Ethics and Behavior 12:75-86, 2002
54. Kavanaugh K, Ayres L: "Not as bad as it could have been": assessing and mitigating harm during research interviews on sensitive topics. Research in Nursing and Health 21:91-97, 1998
55. Oquendo MA, Stanley B, Ellis SP, et al: Protection of human subjects in intervention research for suicidal behavior. American Journal of Psychiatry 161:1558-1563, 2004